Alain H. Rook

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management”.

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Dermatology and Therapy(2021)10.1007/s13555-021-00624-7

N/A

0DataRank · unranked

44 citations

Kerri E. Rieger, M. Bagot, Jennifer Choi, David C. Fisher, Joan Guitart +11 more

Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma

Blood(2022)10.1182/blood.2021014468

N/A

0DataRank · unranked

38 citations

George E. Durán, Sebastian Fernandez‐Pol, Alain H. Rook, Youn H. Kim, Michael S. Khodadoust +1 more

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones

Blood Advances(2022)10.1182/bloodadvances.2022008798

N/A

0DataRank · unranked

10 citations

Mathilde Poussin, Alba Rodríguez-García, Joshua T. Eggold, Nicholas G. Minutolo, Jie Wang +4 more

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Science Immunology(2024)10.1126/sciimmunol.adn6509

N/A

0DataRank · unranked

48 citations

Guido Ghilardi, Yunlin Zhang, Yi‐Hao Chiang, Wei Xie, Puneeth Guruprasad +46 more

Preliminary evaluation of the safety and feasibility of toll-like receptor ligand CB101 combined with hypofractionated radiation therapy in canine head and neck cancer: a pilot study

Veterinary oncology.(2025)10.1186/s44356-025-00031-6

N/A

0DataRank · unranked

1 citations

June DiBona, Lili Duda, Xiaowei Xu, John N. Lukens, Tillman Pearce +6 more